Origins - The Patient Focused Specialists

Strategy: Patient focused strategies throughout the product lifecycle

Insights: Patient and caregiver focused insights

Data: Patient experience data to support regulatory approvals and assessments

Solutions:  Patient education, communication and support solutions

Origins' Knowledge Centre

A collection of resources including webinar recordings, publications and short videos to help you be more patient focussed

ORIGINS cements its specialist position with a truly patient focused offering

Origins are the patient focused specialists that create and deliver strategy, insights, experience data and solutions across the product lifecycle

FREE WEBINAR: End-to-end patient strategy: making a treatment for patients, with patients

Origins announces the first speaker on the panel of our upcoming webinar

ORIGINS INSIGHTS EVOLVES INTO PATIENT SPECIALIST AGENCY

Deeper focus on patient engagement across the pharma/biotech product lifecycle

Mark Corbett explains why Origins is evolving

Resonant Group Chief Innovation Officer, Mark Corbett has released a video explain why Origins is evolving from a Patient Insights agency to a Patient Focused Specialist agency.

MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP

Two additional leadership moves also strengthen management team

Using ethnography to uncover the authentic patient experience

Ahead of their webinar on 7th June ‘Revealing the true patient experience through ethnography’, Su Smith, Director of Origins Insights, looks at the benefits of ethnography from a patient and client perspective.

Were patients at the heart of your New Year’s Resolutions?

Over recent years, many pharma companies have increasingly stated that they have patients at the heart of their success objectives... but if they were to look back and decide whether they have kept or failed this resolution, would they truly be able to say they had succeeded?

Understanding the authentic patient experience can redefine the success of your clinical trial before you design it

. Su contributes our experience are Origins that there is a willingness within the Pharmaceutical Industry to change attitudes towards clinical trial populations – making them less about academic and clinical outcomes and more inclusive of patient experience and priorities.

RESONANT GROUP APPOINTS STEPHEN MARCHANT CHIEF DEVELOPMENT OFFICER

Stephen Marchant has joined Resonant Group in the newly created role of Chief Development Officer.  He will be working with the Board to create, grow and acquire businesses and services to support changing client needs, as well as developing new approaches to the identification, support and recruitment of a diverse team of people to deliver real change in the healthcare communications sector. Anna Korving has also joined Resonant Group as a part-time non-executive director and advisor to the Board.

Origins Insights nominated for two EVCOM Clarion Awards

Origins Insights excited to have our 'What One Thing...?' RDD film shortlisted for two awards!

Origins Insights wins the “Best Patient-Centric Approach” award at the BHBIA BOBI Awards 2021

Origins Insights thrilled to be named as winners at the BHBIA BOBI Awards 2021

Why we need to look at rare diseases in a different way

28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives.

End-to-end patient strategy: Making a treatment for patients, with patients

The integration of patient engagement in all stages of a product lifecycle is starting to become much more commonplace and you may start to hear the term end-to-end patient strategy used more and more often. But what does ‘end-to-end’ encompass, and what does this mean for drug development companies, regulators, healthcare professionals and, of course, patients themselves? Here we explore the concept and why patient voices need to be loud, and heard, during all phases of drug development...